Skip to search formSkip to main contentSkip to account menu

Telomelysin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
TPS4145 Background: Although checkpoint inhibitors (CPIs) can produce durable responses in gastric cancer patients (pts) in the… 
Highly Cited
2013
Highly Cited
2013
On paper at least, the telomerase enzyme seems like a perfect cancer target. Telomerase expression is essential for the… 
2013
2013
This study investigated the pathway underlying the antitumor activity of telomelysin, a telomerase‐dependent, replication… 
2011
2011
PurposeA telomerase-specific oncolytic adenovirus, Telomelysin, can selectively kill cancer cells, and be attenuated in normal… 
2010
2010
Multimodal approaches combining drugs that differentially function is the most popular regimen for treating human cancer… 
2010
2010
S cientists are targeting telom-erase in various ways to kill cancer cells. Most recently, a team led by in Dallas, used an… 
Highly Cited
2009
Highly Cited
2009
We previously constructed telomerase-dependent, replication-selective adenoviruses OBP-301 (Telomelysin) and OBP-401 [Telomelysin… 
2009
2009
Telomelysin (OBP-301) is a telomerase-specific replication-component adenovirus. Telomelysin has a human telomerase reverse… 
2009
2009
SummaryWe constructed a replication-competent oncolytic adenovirus, OBP-301 (Telomelysin), in which human telomerase reverse…